SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : 50% Gains Investing -- Ignore unavailable to you. Want to Upgrade?


To: Dale Baker who wrote (12657)12/4/1999 8:51:00 AM
From: Richard TsangRespond to of 118717
 
Always a pleasure to read your portfolio update, which reminds me to do some re-evaluation of my holdings.

Mine is 118% YTD. Overlaps are: AOL, COMS, VRIO, MSGI, MGIC, WPNE, FFTI, BINC, CNCR, OPAY, SCOC, DSET

My other holdings: (long term)- AGS, AXNT, BLSC, CHRZ, MVIS, MAKR, NETE, FNDT, EGAN, PYTL, ICO, HTCH, INVX, BLSW, SFE

(short term/trading) MDCM, SWS, NETM, BOSC, INPH, DMIC, EGOV, SBEI, PTIX, BITS, FORM, HOOV, VSNT

Leftovers from IPO's (50 = sold half at double or more and keeping 50 shares) - BFRE(50), JFAX, JNIC(50), JPTR(50), ISPD, DCCA, ESPS, QNTS(50), VOYN, ZANY, EDGR

I have to thank the IPO's for providing additional cashflow. OTOH, I learned a big lesson by losing a big chunk on shorting the wrong stocks. Oh, well, I am learning! Agrrrrr

Need to cut down next week and will look at the losers first.

Rich



To: Dale Baker who wrote (12657)12/4/1999 9:56:00 AM
From: SoftechieRead Replies (1) | Respond to of 118717
 
I'm looking for shorts candidates for January and February 2000 play. You have any recommendations?



To: Dale Baker who wrote (12657)12/4/1999 12:06:00 PM
From: Mike McFarlandRespond to of 118717
 
I think Genset is a cheap stock in a hot
sector, and it might fit into the biotech
portion of your portfolio very nicely.
I expect it to rise 50% in the next
few months. Disclaimer, I own 700 shares
and my target is $20 next year.

I found an article somebody posted which
talks about genomics, it's a good one to read.
Message 12184518
I was surprised to see Ariad mentioned in the article,
that is my largest position, but not suited for
your portfolio, too speculative, but great upside.

A second suggestion for the biotech portion of your
portfolio would be Valentis, VLTS. This player in
the area of gene therapy was my entry into the next
dartboard contest on the WSJ, I own 1500 shares and
think the stock could be long term ten bagger,
but would settle for $15 next year. The VLTS thread
is pretty much just me right now, but I would love
to see some newbies join me.
Subject 27855